Indian Authorities Propose Use of Homeopathy to Prevent Coronavirus

Critics of the practice say the guidance is irresponsible and could give users a false sense of security.

alakananda dasgupta
| 5 min read
arsenicum album homeopathy coronavirus india 2019-ncov

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM, VGAJIC

The Indian government’s Ministry of AYUSH, which promotes alternative medicine systems in the country, released a health advisory on January 29 that advocates the use of homeopathy and traditional remedies, such as Indian systems of medicine, to ward off infections of the newly circulating 2019-nCoV coronavirus. This includes the use of a homeopathic preparation called Arsenicum album 30C and two drops of sesame oil in each nostril each morning for prevention, and Unani medicines (treatments based on the teachings of Hippocrates and Galen) to mitigate symptoms of coronavirus infection. While AYUSH cites centuries of practitioners’ experiences with these products as evidence behind its advice, the media and the scientific community criticized the guidance as being counterproductive in dealing with a serious health emergency.

“It is profoundly irresponsible of the Ministry of AYUSH to endorse homeopathy as this entirely undermines public understanding of science and medicine, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • alakananda dasgupta

    Alakananda Dasgupta

    Alakananda Dasgupta is a freelance science journalist based in New Delhi, India, who contributes to The Scientist. She is a medical doctor and a pathologist by training. In 2018, she combined her interests in science and writing and became a science writer. She has done research previously in the field of immunology and is currently writing a book on the subject.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo